121 related articles for article (PubMed ID: 38868302)
1. Diagnostic Value of Microbial Cell-free DNA Sequencing for Suspected Invasive Fungal Infections: A Retrospective Multicenter Cohort Study.
Huygens S; Schauwvlieghe A; Wlazlo N; Moors I; Boelens J; Reynders M; Chong GL; Klaassen CHW; Rijnders BJA
Open Forum Infect Dis; 2024 Jun; 11(6):ofae252. PubMed ID: 38868302
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients.
Buess M; Cathomas G; Halter J; Junker L; Grendelmeier P; Tamm M; Stolz D
BMC Infect Dis; 2012 Oct; 12():237. PubMed ID: 23031334
[TBL] [Abstract][Full Text] [Related]
4. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
6. Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis.
Mah J; Nicholas V; Tayyar R; Moreno A; Murugesan K; Budvytiene I; Banaei N
Clin Infect Dis; 2023 Nov; 77(9):1282-1290. PubMed ID: 37450614
[TBL] [Abstract][Full Text] [Related]
7. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease.
Springer J; White PL; Kessel J; Wieters I; Teschner D; Korczynski D; Liebregts T; Cornely OA; Schwartz S; Elgeti T; Meintker L; Krause SW; Posso RB; Heinz WJ; Fuhrmann S; Vehreschild JJ; Einsele H; Rickerts V; Loeffler J
J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29187564
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.
Hill JA; Dalai SC; Hong DK; Ahmed AA; Ho C; Hollemon D; Blair L; Maalouf J; Keane-Candib J; Stevens-Ayers T; Boeckh M; Blauwkamp TA; Fisher CE
Clin Infect Dis; 2021 Dec; 73(11):e3876-e3883. PubMed ID: 33119063
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit.
Talento AF; Dunne K; Joyce EA; Palmer M; Johnson E; White PL; Springer J; Loeffler J; Ryan T; Collins D; Rogers TR
J Crit Care; 2017 Aug; 40():119-127. PubMed ID: 28384600
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary aspergillosis and aflatoxins in chronic lung diseases.
Ali S; Malik A; Shahid M; Bhargava R
Mycopathologia; 2013 Oct; 176(3-4):287-94. PubMed ID: 23948964
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
13. Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities.
Reinwald M; Spiess B; Heinz WJ; Heussel CP; Bertz H; Cornely OA; Hahn J; Lehrnbecher T; Kiehl M; Laws HJ; Wolf HH; Schwerdtfeger R; Schultheis B; Burchardt A; Klein M; Dürken M; Claus B; Schlegel F; Hummel M; Hofmann WK; Buchheidt D
J Clin Microbiol; 2013 Dec; 51(12):4178-85. PubMed ID: 24108612
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
[TBL] [Abstract][Full Text] [Related]
16. Performance of Targeted Fungal Sequencing for Culture-Independent Diagnosis of Invasive Fungal Disease.
Gomez CA; Budvytiene I; Zemek AJ; Banaei N
Clin Infect Dis; 2017 Nov; 65(12):2035-2041. PubMed ID: 29020284
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
[TBL] [Abstract][Full Text] [Related]
19. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
Thornton C; Johnson G; Agrawal S
J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
[TBL] [Abstract][Full Text] [Related]
20. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
